Dermapharm Holding SE (LON:0A5J)

Paramount Global Revenue

Dermapharm Holding SE had revenue of 305.26M EUR in the quarter ending March 31, 2025, with 1.27% growth. This brings the company's revenue in the last twelve months to 1.20B, up 6.20% year-over-year. In the year 2024, Dermapharm Holding SE had annual revenue of 1.20B with 3.89% growth.

• Revenue (ttm): 1.20B EUR
• Revenue Growth: +6.20%
• P/S Ratio: 1.50
• Revenue / Employee: 332.22K EUR
• Employees: 3,610
• Market Cap: 1.51B USD

Revenue Chart

* This company reports financials in EUR.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	1.20B	44.72M	3.89%
Dec 31, 2023	1.15B	110.19M	10.59%
Dec 31, 2022	1.04B	80.46M	8.38%
Dec 31, 2021	960.09M	151.78M	18.78%
Dec 31, 2020	808.31M	93.94M	13.15%